By using proteomic and expression profiles, Broniszet et al. reported that the ablation of the phosphatase and tensin homolog (PTEN) gene in mammary stromal fibroblasts activates an oncogenic secretome, accompanied by the downregulation of miR-320 and the transition of NFs into CAFs in breast cancer [72]. Here, PTEN is linked to breast cancer.